Cannabis usage rates are spiking for older generations
According to new data research published by JAMA, Americans 65 and older are using more cannabis than ever before. Since 2015, the amount of total senior citizens using medical or adult-use cannabis doubled in states that offered a legalized market. In 2006, just 0.4% of Americans older than 65 reported using cannabis in the past year, but in 2020, that figure has risen above 4% – signaling a clear upwards trend for a group that was once an afterthought.
“I find it fascinating that people who would never touch an illegal drug are now trying to get it, even if it’s just for medical purposes,” study co-author Joseph Palamar told CNN.
Besides legalization, a number of factors are likely contributing to the consistent surge; including an expansion of ratio-specific products that include non-psychoactive cannabinoids, an increase of medical research, and the innovation of new, friendlier medicines like topicals and gummies.
Department of Financial and Professional Regulation releases new guidelines in Illinois
With businesses shutting down due to the COVID-19 pandemic, Illinois lawmakers have quickly added reassurance to the medical cannabis community; releasing new guidelines for dispensaries, which includes limits on the amount of person(s) that can be in-store or outside, as well as new cautionary sanitation practices.
“Our top priority is to minimize the risk of and protect as many people from exposure to COVID-19,” said Toi Hutchinson, Senior Advisor for Cannabis Control to Governor Pritzker. “These steps prioritize that critical objective, while also ensuring medical patients have access to the medicine they need.
Cannabis could reduce ADHD symptoms and medications, finds new study
Israel’s Ministry of Health continues to lead the charge on groundbreaking cannabis studies, making the nation one of, if not the largest host of researchers studying the plant.
A recent study funded by the department, and carried out by The Evelyn Gruss Lipper Charitable Foundation, found that high-THC and high-CBD cannabinoids can greatly reduce common symptoms found in patients with ADHD.
Pooling together researchers from universities across the nation, the study focused on 53 long-term medical patients who were previously diagnosed with ADHD. The 53 participants were then grouped into two separate groups, divided by high and low-dosed usage.
Researchers used a plethora of data to sort through what’s working, and what isn’t, relying on patients honest feedback after 3 increments of usage (immediate effects, 30 mins, and 1 hour).
The cannabinoids most associated with reduced or eliminated ADHD medication and/or symptoms included CBN, THC, THCV and CBD.
Alabama inches closer towards legalization
After passing a key-committee, a bill that would legalize medical cannabis in the Heart of Dixie has passed through the Senate, signaling a major win for local advocates in the state as it is the furthest a cannabis-focused bill has ever gone in either branches of govt.
The bill, SB165, provides detailed regulatory framework that is designed to speed-up the process, if approved, leaning on nearby states policies for a quick roll-out. A commission titled “The Alabama Medical Cannabis Commission” would be in charge of reviewing and distributing licenses, and would advise on any amendments needed.
Qualifying conditions include anxiety, autism, cancer, Chrons-diseases, epilepsy, fibromyalgia, HIV/AIDS, PTSD, tourette’s syndrome, and sleeping disorders.
A House committee vote is expected in the coming months, and despite still facing an uphill battle, it’s a clear indication that cannabis policies and stigmas are rapidly changing in America’s bible belt.